Emcure Pharma IPO listing today, GMP down | Buy, Sell or Hold? Expert’s advice

Emcure Pharma IPO listing today, GMP down | Buy, Sell or Hold? Expert’s advice

New Delhi: Emcure Pharma IPO will be listed on July 10, 2204, i.e. Wednesday. Stock market expert, Arun Kejriwal told Money9 that if Emcure Pharma shares are listed with gains of above 40 per cent, retail investors should not buy the stock. He advised investors to buy the scrip if the shares do not list at a high premium.

Kejriwal further said that the stock is getting listed at a time when Budget 2024 is around the corner. Market can be volatile in run up to Budget 2024. So, one should not have too much expectation on performance of Emcure Pharma shares post listing.

Emcure Pharma IPO GMP has fallen ahead of the listing. The IPO was subscribed multifold by the time the stake sale process closed for subscription on July 5.

Emcure Pharma IPO GMP today

Emcure Pharma IPO GMP declined to Rs 300 in the grey market, according to Investor Gain. The stock’s latest grey market premium and upper limit of Emcure Pharma IPO price band of Rs 960-1,008, indicates that the listing price would be Rs 1,310 per share. Albeit, GMP cannot be considered as an official number.

Emcure Pharma IPO Result

Emcure Pharma IPO Subscription Status had crossed 67X mark by the end of day three. While, the IPO retail quota was oversubscribed 7 times the allotted size. Emcure Pharma IPO NII Subscription Status stood at 49X, while the IPO in QIB quota was oversubscribed by a massive 191 times.

Investors who had applied for the IPO can check Emcure Pharma IPO allotment status either on the company’s registrar’s website or on the BSE. Shark Tank fame Namita Thapar is expected to get Rs 128 crore as she had offered to sell her stake in the public issue. Thapar is expected to make 290X her initial investment value in the pharma company.

(Disclaimer: This article is only meant to provide information. News9live.com does not recommend buying or selling shares or subscriptions of any IPO and Mutual Funds.)

 Emcure Pharma IPO’s current GMP indicates Emcure Pharma IPO listing price of Rs 1,360 per share on Wednesday, July 10, 2024.  Markets Business News – Personal Finance News, Share Market News, BSE/NSE News, Stock Exchange News Today